We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mechanical Ventilation Leads to Diaphragm Muscle Thinning

By HospiMedica International staff writers
Posted on 10 Jul 2012
A new study shows that mechanical ventilation (MV) has an unloading effect on the respiratory muscles, leading to diaphragmatic atrophy and dysfunction.

Researchers at the Columbia University College of Physicians and Surgeons (New York, NY, USA) followed seven intubated patients receiving MV during acute care. More...
The researchers measured diaphragm muscle thickness daily using sonography to quantify the rate and degree of diaphragm thinning during MV, a process known as ventilator-induced diaphragmatic dysfunction (VIDD). Daily measurement continued from the day of intubation until the patient underwent extubation, or tracheostomy, or died. The researchers then analyzed the data using standard descriptive statistics, linear regression, and mixed model effects.

The results showed that diaphragm muscle thinning starts within 48 hours after initiation of MV. The overall rate of decrease in the diaphragm thickness of all seven patients over time averaged 6% per day of MV, which differed significantly from zero. Similarly, the diaphragm thickness decreased for each patient over time.

“The purpose of this study was to quantify, using daily sonographic assessments, the rate and degree of diaphragm thinning during MV,” concluded lead author Horiana Grosu, MD, and colleagues of the division of pulmonary critical care and sleep medicine. “However, it is unclear if diaphragmatic thinning correlates with diaphragmatic atrophy or pulmonary function.”

VIDD results from a number of changes in the ventilatory muscles. First, at the macroscopic level, muscle atrophy occurs, representing a global reduction in the muscle mass and the cross sectional area of muscle fibers. At the ultrastructural level, observed changes include myofibrillar loss, mitochondrial abnormalities, and vacuole development. Third, there is biochemical evidence for oxidative stress and protein breakdown within the muscles. Lastly, at the genetic level, at least 354 gene expressions have been associated with controlled mechanical ventilation (CMV) and thus possibly VIDD.

Related Links:

Columbia University College of Physicians and Surgeons


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.